During the past decade, Metroplex Clinical Research Center conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 48 clinical trials were completed, i.e. on average, 82.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 30 clinical trials were completed. i.e. 136.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metroplex Clinical Research Center" #1 sponsor was "Pfizer" with 18 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored, "Genentech, Inc." with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metroplex Clinical Research Center" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Metroplex Clinical Research Center" are "Rheumatoid Arthritis" (33 trials), "Systemic Lupus Erythematosus" (13 trials), "Arthritis, Rheumatoid" (7 trials), "Osteoarthritis" (6 trials) and "Lupus Erythematosus, Systemic" (5 trials). Many other conditions were trialed in "Metroplex Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Metroplex Clinical Research Center" are "Drug" (79 trials), "Biological" (18 trials), "Other" (12 trials), "Device" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Baricitinib" (8 trials), "Methotrexate" (8 trials), "Adalimumab" (5 trials) and "Abatacept" (4 trials). Other intervention names were less common.

The vast majority of trials in "Metroplex Clinical Research Center" are 94 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Metroplex Clinical Research Center". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 66 completed trials in Metroplex Clinical Research Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Metroplex Clinical Research Center, 22 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 2 trials that are defined as “Not Applicable".